Wednesday, October 31, 2018

Dr Reddy#39;s Labs announces generic version of Straterra in US market

Dr Reddy#39;s Labs announces generic version of Straterra in US market The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equivalent of Eli Lilly and Company#39;s Straterra, Dr Reddy#39;s Laboratories said in a statement.

from Moneycontrol Business News https://ift.tt/2Q8mei6

No comments:

Post a Comment

BSE shares jump 3% to break two-day losing streak amid Sebi board meet buzz

BSE shares experienced a surge, climbing as high as 2.7% following reports that Sebi's board meeting wouldn't address ending weekly ...